Skip to main content
OpenTrials

Clinical trial condition

RNA Virus Infections

Explore clinical trials studying RNA Virus Infections. Study availability and eligibility vary by location and protocol.

80 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

RNA Virus Infections trial results

Completed

VIR-7831 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

NCT05780281

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • Banner University Medical Center Tucson (Site 206-004), 1625 N. Campbell Avenue Tucson, Arizona, United States
  • Southern Arizona VA Healthcare System (Site 074-009), 3601 S. 6th Ave. Tucson, Arizona, United States
  • Community Regional Medical Center (Site 203-005), 2823 Fresno Street Fresno, California, United States
  • VA Loma Linda Healthcare System (Site 074-017), 11201 Benton Street Loma Linda, California, United States
View all 105 locations
View Trial Details
Completed

ACTIV-3: Therapeutics for Inpatients With COVID-19

NCT04501978

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +11 more
Locations
  • Banner University Medical Center Tucson (Site 206-004), 1625 N. Campbell Avenue Tucson, Arizona, United States
  • Southern Arizona VA Healthcare System (Site 074-009), 3601 S. 6th Ave. Tucson, Arizona, United States
  • Velocity Chula Vista (Site 080-034), 752 Medical Center Ct., Ste. 304 Chula Vista, California, United States
  • Community Regional Medical Center (Site 203-005), 2823 Fresno Street Fresno, California, United States
View all 135 locations
View Trial Details
Completed

Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles (VLPs) Influenza Vaccine in Adults

NCT03301051

Conditions
Infections, Influenza, Influenza, Human, +5 more
Locations
  • Site 222 Mobile, Alabama, United States
  • Site 210 Anaheim, California, United States
  • Site 223 Milford, Connecticut, United States
  • Site 217 Coral Gables, Florida, United States
View all 73 locations
View Trial Details
Completed

Efficacy of a Plant-derived Quadrivalent Virus-like Particle (VLP) Vaccine in the Elderly

NCT03739112

Conditions
Infections, RNA Virus Infections, Respiratory Tract Diseases, +2 more
Locations
  • (Site 225) Coastal Clinical Research Mobile, Alabama, United States
  • (Site 201) Clinical Research Consortium Tempe, Arizona, United States
  • (Site 213) Advanced Clinical Research Banning, California, United States
  • (Site 246) Paradigm Clinical Research / Pharmaseek Redding, California, United States
View all 104 locations
View Trial Details
Completed

Safety and Immunogenicity of mRNA-1653, a Combined Human Metapneumovirus (hMPV) and Parainfluenza Virus Type 3 (PIV3) Vaccine, in Healthy Adults, and Children 12 to 59 Months of Age With Serologic Evidence of Prior Exposure

NCT04144348

Conditions
Human Metapneumovirus and Human Parainfluenza Infection, Infections, Mononegavirales Infections, +3 more
Locations
  • Central Research Associates Inc Birmingham, Alabama, United States
  • Meridian Clinical Research Washington D.C., District of Columbia, United States
  • Clinical Research Prime Idaho Falls, Idaho, United States
  • Heartland Research Associates LLC El Dorado, Kansas, United States
View all 19 locations
View Trial Details

Related conditions